'김갑성' 기자의 전체기사
-
WuXi AppTec Receives Double "A" Rating from CDP for Climate Ch…
SHANGHAI, Jan. 19, 2026 -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has been recognized on the "A List" for leadership in corporate transparency and performance across both Climate Change and Water Security by CDP (Carbon Disclosure Project). This recognition, which represents CDP's highest rating in each category, underscores WuXi AppTec's achievements in climate change and water resource management and its ongoing commitment to sustainable development. CDP is a global non-pro
- 김갑성 기자
- 2026-01-19 08:00
-
A Smarter New Year's Resolution: Investing in Eye Comfort for Sc…
SYDNEY, Jan. 19, 2026 -- As the new year begins, many Australians are setting resolutions focused on health, balance and long-term wellbeing. While fitness goals and productivity upgrades often dominate the conversation, eye comfort during extended screen use is frequently overlooked. With work, communication and entertainment increasingly centred around screens, visual fatigue has become a common challenge, particularly for those spending long hours at a desk. Improving the environment around the screen is a practical way to support healthier work habits throughout the year. &n
- 김갑성 기자
- 2026-01-19 08:00
-
Kerry、2026年サプリメント味覚チャートを発表：サプリメントとスポーツ栄養における…
シンガポール、2026年1月17日 -- 味覚と栄養分野の世界的リーダーであるKerryは、アジア太平洋地域および中東向けの2026年サプリメント味覚チャートを発表しました。このチャートは、同地域における味覚嗜好の変化と、風味重視・ライフスタイル主導型のサプリメントおよびスポーツ栄養製品の台頭を浮き彫りにしています。 アジア太平洋・中東・アフリカ（APMEA）全域で、サプリメントは一時的な健康サポートではなく、日常のウェルビーイングの一部として認識される傾向が強まっています。消費者は睡眠、免疫力、消化機能、ストレス管理、エネルギー補給、情緒安定といった効果に注目しており、味と食感が継続購入や長期使用に大きく影響するようになりました。 世界のサプリメント市場は2029年までに1070億米ドル規模に達すると予測され、APMEA地域は引き続き強い成長勢いを示しています。中国、インド、東南アジア、中東が普及を牽引しており、健康意識の高まり、多忙なライフスタイル、パーソナライズド栄養への関心拡大がこれを支えています。 風味重視のトレンドがサプリメントを再定義 消費者は従来の錠剤から離れ、グミ、チュアブル、ドリンクミックス、溶解ストリップ、パウダーブレンドなど風味を前面に出した形態へと移行しています。こ
- 김갑성 기자
- 2026-01-17 23:35
-
케리, 2026년 보충제 맛 차트 발표: 보충제 및 스포츠 영양의 다음 시대 규정
싱가포르 2026년 1월 17일 -- 맛과 영양 분야의 글로벌 리더인 케리(Kerry)가 아시아 태평양 및 중동 지역을 대상으로 한 2026년 영양 보충제 맛 차트(2026 Supplements Taste Charts)를 발표했다. 이 차트는 해당 지역에서 진화하는 맛 선호도를 강조하고 풍미를 중시하며 라이프스타일이 주도하는 보충제와 스포츠 영양 제품의 부상을 조명했다. 아시아 태평양, 중동 및 아프리카(APMEA) 전역에서 보충제는 일시적인 건강 지원 수단이 아닌 일상적인 웰빙의 일부로 인식되는 경향이 커지고 있다. 소비자들은 수면, 면역력, 소화, 스트레스 관리, 에너지 및 정서적 균형과 같은 혜택에 집중하고 있으며, 이제 맛과 식감이 지속적인 구매와 장기 복용에 강력한 영향을 미치고 있다. 글로벌 보충제 시장은 2029년까지 미화 1070억 달러 규모에 달할 것으로 예상되며, APMEA 지역은 계속해서 강한 성장세를 보이고 있다. 중국, 인도, 동남아시아 및 중동 지역은 높아지는 건강 의식, 바쁜 라이프스타일, 그리고 개인 맞춤형 영양에 대한 관심이 증가함에 따라 시장 성장을 주도하고 있다.&nbs
- 김갑성 기자
- 2026-01-17 09:42
-
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diag…
MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Biopsy of the Prostate Avoidance Stratification Study), a Phase 3 trial to evaluate the use of Telix's commercial PSMA-PET[1] imaging agents, Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection) and Gozellix® (kit for the preparation of gallium Ga 68 gozetotide injection) in the initial prostate cancer diagnosis setting. The dose was ad
- 김갑성 기자
- 2026-01-17 03:21
-
POMDOCTOR LIMITED Drive Internet Hospital Growth Through Stren…
GUANGZHOU, China, Jan. 16, 2026 -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced significant progress in its strategic collaboration with leading domestic pharmaceutical companies to accelerate the growth of its internet hospital business. The Company expects these partnerships to become a core component of its long-term strategy to expand online hospital operations and enhance overall profitability. Against the backdrop of China's accelerating population agin
- 김갑성 기자
- 2026-01-16 22:00
-
NUH INAUGURATES NEW CENTRE TO ADVANCE PREDICTIVE AND ACCESSIBLE…
The National University Centre for Digestive Health heralds a new era of care through quicker cross-referrals to surgical specialties, strengthened community partnerships and patient-friendly treatment delivery SINGAPORE, Jan. 16, 2026 -- Digestive health is central to overall well-being, influencing nutrition, immunity, and quality of life. Yet common conditions, such as ulcers, liver disease, and colorectal disorders, often go undetected until they lead to serious complications. To address this, the National University Hospital (NUH) has officially opened the National Univers
- 김갑성 기자
- 2026-01-16 22:00
-
Henlius Showcases "Globalisation 2.0" Strategy and Mid-to-L…
SAN FRANCISCO, Jan. 16, 2026 -- The 44th J.P.Morgan Healthcare Conference (JPMHC) was successfully held in San Francisco, the United States, from January 12 to 15. As one of the most influential annual events in the global healthcare sector, JPM serves as a key platform for the capital markets and industry leaders to observe emerging trends in pharmaceutical innovation and industry development. The conference attracted more than 8000 global industry leaders, innovators, entrepreneurs, and investors. On January 15 (PST), Dr. Jason Zhu, Executive Director and Chief Executive Officer of Shanghai
- 김갑성 기자
- 2026-01-16 21:00
-
Taiwan-U.S. Innovation Link Strengthened: Startup Island TA…
TAIPEI, Jan. 16, 2026 -- To accelerate the co-development of Taiwan–U.S. startup ecosystems in artificial intelligence (AI), semiconductors, and advanced technologies, Startup Island TAIWAN, the national startup brand guided by Taiwan's National Development Council (NDC), today announced the signing of a Memorandum of Understanding (MOU) with the City of Phoenix, the Greater Phoenix Economic Council (GPEC), and Tesoro Venture Capital, in collaboration with the Industrial Technology Research Institute (ITRI). Building on TSMC's expansion in Phoenix, the partnership aims to integrate Tai
- 김갑성 기자
- 2026-01-16 14:44
-
Zylox-Tonbridge to Acquire Equity Interest in A European Med…
[ 메디채널 김갑성 기자 ] Marks a major milestone in Zylox-Tonbridge's long-term commitment to global expansion Builds an integrated global commercialization platform to accelerate Zylox-Tonbridge's adoption of innovative vascular solutions worldwide Delivers Zylox-Tonbridge's manufacturing and operational synergies across Germany and China Fully unlocks Zylox-Tonbridge's high-efficiency R&D capabilities HANGZHOU, China and BERLIN, Jan. 16, 2026 -- Zylox-Tonbridge (HKEX:2190), a Hong Kong-listed medical technology company focused on neuro-and peripheral vascular interv
- 김갑성 기자
- 2026-01-16 13:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 5하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 6대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 7만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2026-01-31_SAT
- Sanyou Bio's Decade: From an Intelligent Super-Trillion Antibody Library to the "Innovation Hub for Original Drug Discovery" 16:15
- CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK 12:05
- Origin Agritech Announces Fiscal Year 2025 Results 06:00
- White Pearl Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering 05:47
- Planet Green Holdings Corp. Provides Response to Unusual Market Action 05:05
- SKF completes previously announced divestment of non-core aerospace operation in Elgin, USA 03:36
- DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion 03:34
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2026년 01월 31일 17시 40분